EFFECTIVENESS OF ICOSAPENT ETHYL IN MIDDLE EASTERN PATIENTS WITH DYSLIPIDEMIA

被引：0
|
作者：
Odeh, Mohamed [1 ]
Afandi, Bachar [2 ]
机构：
[1] Sulaiman Al Habib Med Grp, Riyadh, Saudi Arabia
[2] Tawam Hosp, Abu Dhabi, U Arab Emirates
来源：
ATHEROSCLEROSIS | 2024年 / 399卷
关键词：
D O I：
10.1016/j.atherosclerosis.2024.118701
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap
    Parhofer, Klaus G.
    Chapman, M. John
    Nordestgaard, Borge G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0J) : J21 - J33
  • [32] Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT
    Olshansky, Brian
    Bhatt, Deepak L. L.
    Miller, Michael
    Steg, Ph. Gabriel
    Brinton, Eliot A. A.
    Jacobson, Terry A. A.
    Ketchum, Steven B. B.
    Doyle Jr, Ralph T. T.
    Juliano, Rebecca A. A.
    Jiao, Lixia
    Kowey, Peter R. R.
    Reiffel, James A. A.
    Tardif, Jean-Claude
    Ballantyne, Christie M. M.
    Chung, Mina K. K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (05):
  • [33] BUDGET IMPACT OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN CATALONIA
    Mistry, C.
    Tilley, L.
    Comin-Colet, J.
    Vitale, G.
    Gaugris, S.
    Jakouloff, D.
    Lopez, S.
    VALUE IN HEALTH, 2024, 27 (12) : S130 - S130
  • [34] Clinical results and mechanism of action of icosapent ethyl
    Borghi, Claudio
    Bragagni, Alessio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 (SUPPB) : B37 - B40
  • [35] Triglyceride lowering drugs: not just icosapent ethyl
    Spence, J. David
    EUROPEAN HEART JOURNAL, 2020, 41 (15) : 1520 - 1520
  • [36] The role of icosapent ethyl in cardiovascular risk reduction
    Goldenberg, Ronald M.
    Cheng, Alice Y. Y.
    Gilbert, Jeremy D.
    Lonn, Eva M.
    Pedersen, Sue D.
    Verma, Subodh
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (05) : 661 - 671
  • [37] Icosapent ethyl in hypertriglyceridaemia: a guide to its use
    Lyseng-Williamson K.
    McCormack P.L.
    Kim E.S.
    Drugs & Therapy Perspectives, 2016, 32 (3) : 91 - 97
  • [38] Icosapent-Ethyl: Welche Patienten profitieren?
    Dirk Einecke
    MMW - Fortschritte der Medizin, 2021, 163 (10) : 65 - 65
  • [39] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
    Basha, M. Aseem
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2019, 5 (01) : 44 - 47
  • [40] Icosapent Ethyl for Treatment of Elevated Triglyceride Levels
    Nelson, Scott D.
    Munger, Mark A.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1517 - 1523
12345